Utah initially only permitted CBD for medical use, but voters have since approved a full medical marijuana law at the ballot. Whole-plant medical cannabis is now legal for treatment of a long list of conditions, although the program is not yet operational.
ALS (Lou Gehrig’s disease), Alzheimer’s disease, Autism, Cachexia, Cancer, Crohn’s disease or ulcerative colitis, HIV/AIDS, Epilepsy or a similar condition that causes “debilitating seizures”, Multiple sclerosis or persistent and debilitating muscle spasms, Nausea (must be persistent), Pain lasting longer than two weeks that is not adequately managed despite treatment attempts, PTSD “that is being treated or monitored by a licensed mental health therapist”, Any terminal illness where life expectancy is less than six months and any condition resulting in hospice care, Any rare condition that effects fewer than 200,000 persons in the United States as defined by Section 526 of the Federal Food, Drug and Cosmetic Act and is not adequately managed despite treatment attempts.
**Patients with a qualifying illness between the ages of 18 and 21 must petition the Compassionate Use Board for medical cannabis approval
PATIENT POSSESSION LIMITS:
Medical cannabis products can come in the following forms: “tablet,” “capsule,” “a concentrated oil,” “a liquid suspension,” “a topical preparation,” “a transdermal preparation,” “a sublingual preparation,” “a gelatinous cube or lozenge,” or “a blister pack of unprocessed cannabis flower.” All medical products must be labelled with a barcode. Patients are permitted to purchase up to a 14-day supply at a time.
No. Replacement legislation enacted by the House and Senate rewrote the Utah Medical Cannabis Act to prohibit home grows.
Yes, although they are defined as ‘medical pharmacies’ under the replacement legislation. No more than seven medical pharmacy licenses may be issued.
Yes. A patient may designate a maximum of two caregivers, who are permitted to purchase, transport, or otherwise assist the patient with his/her use of medicine.